Short description
DNALite Therapeutics is an early-stage preclinical biotechnology company.
Description
DNALite Therapeutics is an early-stage preclinical biotechnology company committed to bringing the next generation of drugs to the gastrointestinal tract. It develops oral lipid nanoparticle technology to deliver mRNA and pDNA into the intestine using the oral route of administration. Its drug aims to use the intestinal tract to secrete proteins into the bloodstream turning any protein biologic into an oral drug.
Last funding
Cannot Access
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
San Francisco, California, United States, North America
Founded on
January 1, 2016
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$56378 - 90123
Sign in for full access
Investors
Noaccessforu, Cannot Access, Blurry Noaccess, Cannot Access, Cannot Access, Blurry Noaccess, Absolutely Noaccess, Absolutely Noaccess, Nopepepe
Sign in for full access
Founders
Mubhij Ahmad, Timothy Day